LISATA THERAPEUTICS, INC. Depreciation
LISATA THERAPEUTICS, INC. (LSTA) reported Depreciation of $5.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-06
- LISATA THERAPEUTICS, INC. depreciation for the quarter ending 2026-06-30 was $3.00K, a 88.46% decline year-over-year.
- LISATA THERAPEUTICS, INC. depreciation for the quarter ending 2026-03-31 was $2.00K, a 92.31% decline year-over-year.
- LISATA THERAPEUTICS, INC. depreciation for the quarter ending 2025-12-31 was $22.00K, a 4.76% increase year-over-year.
- LISATA THERAPEUTICS, INC. depreciation for the quarter ending 2025-09-30 was $26.00K, a 13.04% increase year-over-year.
- LISATA THERAPEUTICS, INC. depreciation for fiscal 2025 was $100.00K, a 0.00% change from fiscal 2024.
- LISATA THERAPEUTICS, INC. depreciation for fiscal 2024 was $100.00K, a 0.00% change from fiscal 2023.
- LISATA THERAPEUTICS, INC. depreciation for fiscal 2023 was $100.00K, a 0.00% change from fiscal 2022.
- LISATA THERAPEUTICS, INC. depreciation for fiscal 2022 was $100.00K, a 0.00% change from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $5.00K 10-Q · filed 2026-08-06 | $27.00K derived: sum of 3 quarters · filed 2026-08-06 | $53.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $2.00K 10-Q · filed 2026-05-11 | $24.00K derived: sum of 2 quarters · filed 2026-05-11 | $50.00K derived: sum of 3 quarters · filed 2026-05-11 | $76.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $48.00K derived: sum of 2 quarters · filed 2026-03-12 | $74.00K derived: sum of 3 quarters · filed 2026-08-06 | $100.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $52.00K derived: sum of 2 quarters · filed 2026-08-06 | $78.00K 10-Q · filed 2025-11-06 | $99.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $52.00K 10-Q · filed 2026-08-06 | $73.00K derived: sum of 3 quarters · filed 2026-08-06 | $96.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $26.00K 10-Q · filed 2026-05-11 | $47.00K derived: sum of 2 quarters · filed 2026-05-11 | $70.00K derived: sum of 3 quarters · filed 2026-05-11 | $97.00K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $44.00K derived: sum of 2 quarters · filed 2026-03-12 | $71.00K derived: sum of 3 quarters · filed 2026-03-12 | $100.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $50.00K derived: sum of 2 quarters · filed 2025-11-06 | $79.00K 10-Q · filed 2025-11-06 | $90.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $56.00K 10-Q · filed 2025-08-07 | $67.00K derived: sum of 3 quarters · filed 2025-08-07 | $96.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $29.00K 10-Q · filed 2025-05-08 | $40.00K derived: sum of 2 quarters · filed 2025-05-08 | $69.00K derived: sum of 3 quarters · filed 2025-05-08 | $129.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $40.00K derived: sum of 2 quarters · filed 2025-02-27 | $100.00K derived: sum of 3 quarters · filed 2025-02-27 | $100.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | $29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $89.00K derived: sum of 2 quarters · filed 2024-11-12 | $89.00K 10-Q · filed 2024-11-12 | $197.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $60.00K 10-Q · filed 2023-08-14 | $60.00K 10-Q · filed 2024-08-12 | $168.00K derived: sum of 3 quarters · filed 2024-05-09 | |
| 2023-03-31 | $30.00K 10-Q · filed 2024-05-09 | $108.00K derived: sum of 2 quarters · filed 2024-05-09 | ||
| 2022-12-31 | $78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $100.00K 10-K · filed 2024-02-29 | ||
| 2022-09-30 | $22.00K 10-Q · filed 2023-11-02 | |||
| 2022-06-30 | $13.00K 10-Q · filed 2023-08-14 | $20.00K derived: sum of 2 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $7.00K 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | $100.00K 10-K · filed 2023-03-30 | |||
| 2020-12-31 | $100.00K 10-K · filed 2022-03-22 | |||
| 2012-12-31 | $1.00M 10-K · filed 2013-03-11 | |||
| 2011-12-31 | $900.00K 10-K · filed 2013-03-11 | |||
| 2010-12-31 | $200.00K 8-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |